Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TXN vs GSK✓SelectedUSD · GSKTXN vs GSK performance historyLatest closeAs of-7.70%11/20
Stock and ETF performance explorer

TXN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+369.3%
GSK return
+97.4%
Excess return
+271.9%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.7%-0.1%-7.6%-7.7%
7D-13.1%-5.3%-7.8%-11.7%
30D-6.9%-3.7%-3.2%-5.9%
3M-0.2%-7.3%+7.0%+1.8%
6M-12.6%-4.2%-8.4%-12.4%
YTD+55.3%+0.9%+54.5%+52.3%
1Y+75.8%+7.3%+68.5%+68.6%
3Y+84.0%+52.7%+31.2%+49.2%
5Y+55.5%+40.1%+15.4%+28.1%
All+369.3%+97.4%+271.9%+228.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling